EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival

Phan Nhan Hien, Ho Jong Chun, Jung Suk Oh, Su Ho Kim, Byung Gil Choi

Oncology · 2024

DOI: 10.1159/000537867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Phan Nhan Hien und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, hienpn0600@hmuh.…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Liver Neoplasms, Portal Vein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The effectiveness of transarterial chemoembolization (TACE) in treating hepatocellular carcinoma (HCC) has been well established. The differential impacts of drug-eluting bead TACE (DEB-TACE) as opposed to conventional TACE (cTACE) on vascular changes, such as arterial-portal venous shunts (APSs), have been recognized. However, their subsequent effects on treatment outcomes have not been fully explored. This study aims to identify risk factors associated with the occurrence of APS in HCC patients treated with DEB-TACE and to evaluate its impact on patient survival.

Methods

A retrospective analysis was conducted from January 2012 to December 2018 including 74 HCC patients receiving DEB-TACE as initial treatment and a 1:1 cTACE. Kaplan-Meier analysis estimated overall survival (OS) and progression-free survival (PFS). Logistic regression identified significant risk factors for APS occurrence after DEB-TACE.

Results

APS incidence was significantly higher after DEB-TACE than cTACE (46.0% vs. 16.2%, p < 0.001). There was no significant difference in median OS between APS and non-APS groups after DEB-TACE: 50 months (24.6–75.4) versus 26.9 months (19.5–43.2), p = 0.111; median PFS was 15.6 months (4.1–27.1) and 9.5 months (6.8–12.1) for the two groups, respectively, p = 0.065. Risk factors for APS occurrence after DEB-TACE were more than two feeding arteries (OR: 7.25, 95% CI: 1.82–28.95, p = 0.005) and non-selective embolization (OR: 8.02, 95% CI: 2.30–27.95, p = 0.001).

Conclusion

APS occurrence was higher in DEB-TACE-treated HCC patients, but it did not significantly affect OS and PFS. More than two feeding arteries and non-selective embolization were significant risk factors for APS occurrence after DEB-TACE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularChemoembolization, TherapeuticLiver NeoplasmsPortal VeinHumansMaleFemaleRetrospective StudiesMiddle AgedRisk FactorsAgedAdult

Stichwörter der Autor:innen

Aterial-portal venous shuntDrug-eluting bead transarterial chemoembolizationHepatocellular carcinomaPatient survival

Autor:innen und Institutionen

  • Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, hienpn0600@hmuh.vn.
  • Radiology Centre, Hanoi Medical University Hospital, Hanoi, Vietnam, hienpn0600@hmuh.vn.
  • Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Zitieren

APA

Hien, P. N., Chun, H. J., Oh, J. S., Kim, S. H., & Choi, B. G. (2024). Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival. Oncology. https://doi.org/10.1159/000537867

Vancouver

Hien PN, Chun HJ, Oh JS, Kim SH, Choi BG. Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival. Oncology. 2024. doi:10.1159/000537867

BibTeX
@article{Hien2024,
  author = {Hien, Phan Nhan and Chun, Ho Jong and Oh, Jung Suk and Kim, Su Ho and Choi, Byung Gil},
  title = {Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000537867}
}
Kostenlos starten →